Discover on-demand webinars from UK and international ophthalmology experts.
Contact your Novartis representative if you would like to express interest in registering for future events.
Introducing Beovu: An innovation in wet AMD
Current challenges & unmet needs in wet AMD
Mrs Deepali Varma, Consultant Ophthalmologist & Lead clinician macular service at Sunderland Eye Infirmary, discusses challenges physicians currently face and the impact this disease has had on ophthalmology patients seeking treatment.
Why fluid matters in wet AMD
Mrs Deepali Varma, Consultant Ophthalmologist & Lead clinician macular service at Sunderland Eye Infirmary, discusses how to judge if wet AMD is active, types of fluid and management for patients with wet AMD.
Introduction to a new generation anti-VEGF
Robin Hamilton, Honorary Senior Lecturer, Institute of Ophthalmology, and Consultant Ophthalmic Surgeon at Moorfields Eye Hospital, gives an overview of Beovu’s two pivotal trials in adults with wet AMD – the HAWK and HARRIER studies.
Experiencing Beovu: Real-world perspectives
Optimising wet AMD Treatment
Dr Rishi P. Singh, Staff surgeon at the Cleveland Clinic and assistant professor of the Lerner College Cleveland, Ohio, USA, provides an overview of the evolution of wet AMD treatment and his approach to disease management, including the importance of early diagnosis and imaging.
First experience in Germany: Patient cases and implementation
Professor Armin Wolf, Professor of Ophthalmology and Head of Service at the University of Ulm, provides valuable insights into how Beovu is being used in clinics in Germany and early treatment outcomes in patients.
First experience in USA: Patient cases and implementation
Dr Rishi P. Singh provides valuable insights into how Beovu is used in clinics in the USA and treatment outcomes in patients.
Indication: Beovu is indicated in adults for the treatment of neovascular (wet) AMD.1
AMD, age-related macular degeneration.
- Beovu Summary of Product Characteristics, 2020.